BioGaia AB - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for BioGaia AB. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

BioGaia AB. The Group's principal activities are the research, development and manufacturing of probiotic systems that build health in humans and animals. The products of the Group are based on the lactic acid bacterium Lactobacillus reuteri in combination with delivery systems that make it possible to create products with a long shelf life. Reuteri that has probiotic or health-enhancing effects occurs naturally in the intestinal flora of humans and animals. It inhibits the proliferation of harmful bacteria and promotes the growth of the normal intestinal microflora, thereby strengthening the immune system. The trademarks of the Group include Reuteri (R), LifeTop Straw and LifeTop Cap.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report